• Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Rating of "Buy" by Analysts

    Источник: Buzz FX / 07 ноя 2024 01:51:16   America/New_York


    Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Shares of Dianthus Therapeutics, Inc. ( NASDAQ:DNTH - Get Free Report ) have earned
    Read more...
Опубликовать